• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Expression of epidermal growth factor receptors in benign ovarian tumors].

作者信息

Tomov S, Tsingilev D, Gorchev G, Velkova A, Veselinova T

出版信息

Akush Ginekol (Sofiia). 2004;43(4):13-7.

PMID:15318536
Abstract

The objective of the present study was to determine the level of EGFR expression in patients having benign ovarian tumors and in morphologically normal ovarian tissue by quantitative ligand binding assays. In a prospective study 42 patients with benign ovarian tumors and 30 with normal ovaries were included. In the group of patients expressing EGFR, those having benign tumors were 23 (64%) and the ones with normal ovaries--13 (36%). The average level of EGFR expression was the highest in the cases of teratoma adultum (110 fmol/mg), followed by mucinous (97 fmol/mg) and serous (30 fmol/mg) cystadenomas. The differences between the average levels of EGFR expression in mucinous and serous benign ovarian tumors were significant (p = 0.032), as for the remaining histological variants--statistically insignificant (p = 0.086). Mucinous cystadenomas possessed higher proliferative potential compared to serous cystadenomas.

摘要

相似文献

1
[Expression of epidermal growth factor receptors in benign ovarian tumors].
Akush Ginekol (Sofiia). 2004;43(4):13-7.
2
[Determination of epidermal growth factor receptor expression in malignant ovarian tumors using radioligand assay].
Akush Ginekol (Sofiia). 2004;43(2):37-40.
3
Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.卵巢上皮性肿瘤中促卵泡激素受体的定量分析:解释副中肾系统中卵巢癌发生场效应的新方法。
Int J Cancer. 2003 Jan 20;103(3):328-34. doi: 10.1002/ijc.10848.
4
Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome.表皮生长因子受体在浆液性卵巢癌中的表达:一项联合半乳糖凝集素-3和细胞周期蛋白D1的免疫组织化学研究及预后分析
Int J Gynecol Pathol. 2008 Jul;27(3):380-9. doi: 10.1097/PGP.0b013e31815d060d.
5
[Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].ARHI、STAT3和E2F1在卵巢浆液性癌中的表达及临床意义
Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):905-9.
6
Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.葡萄糖转运蛋白1和p63在浆液性卵巢肿瘤中的表达
J Obstet Gynaecol Res. 2014 Jul;40(7):1925-30. doi: 10.1111/jog.12447.
7
Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.磷酸化4E结合蛋白1:一种与卵巢癌生存相关的细胞信号传导标志。
Cancer. 2006 Oct 15;107(8):1801-11. doi: 10.1002/cncr.22195.
8
[Immunohistochemical analysis of epidermal growth factor receptors expression in malignant ovarian tumors].[恶性卵巢肿瘤中表皮生长因子受体表达的免疫组织化学分析]
Akush Ginekol (Sofiia). 2005;44 Suppl 2:42-7.
9
EGFR, HER2÷neu and Ki67 immunoexpression in serous ovarian tumors.浆液性卵巢肿瘤中表皮生长因子受体(EGFR)、人表皮生长因子受体2(HER2÷neu)及Ki67免疫表达情况
Rom J Morphol Embryol. 2012;53(3):563-7.
10
Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.醛脱氢酶 1/表皮生长因子受体共表达是高级别浆液性卵巢癌中高度侵袭性、预后不良亚组的特征。
Hum Pathol. 2013 Aug;44(8):1465-71. doi: 10.1016/j.humpath.2012.12.016. Epub 2013 Mar 1.